RxDoctor Payments Data

Julie Jones, MD

Family Medicine · Plainfield, ILNPI 1598025298

Payments from drug & device makers

$606in general payments, 2019–2025

Across 35 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$153
  • Boehringer Ingelheim$94
  • AstraZeneca$64
  • Biohaven Pharmaceutical Holding Company Ltd.$50
  • Amgen$32
  • Johnson & Johnson$31
  • plus $182 from 8 others

What the payments were for

  • Food & beverage$606100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$606 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$56,249
Medicare patients
148
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$70,017
JardianceEmpagliflozin33$47,725
MounjaroTirzepatide19$22,959
FarxigaDapagliflozin Propanediol16$16,754
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,095
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,398
Wixela InhubFluticasone Propion/Salmeterol12$2,835
Humalog Kwikpen U-100Insulin Lispro13$2,255
Gabapentin82$2,154
Rosuvastatin Calcium134$2,096
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,942
Levothyroxine Sodium177$1,766
Novolog FlexpenInsulin Aspart11$1,676
SynthroidLevothyroxine Sodium23$1,633
Ezetimibe41$1,342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$27$70,01742 claims
Boehringer IngelheimJardiance$94$47,72533 claims
Lilly USA, LLCMounjaro$29$22,95919 claims
AstraZenecaFarxiga$64$16,75416 claims
AbbVieSynthroid, Armour Thyroid$153$1,97035 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Plainfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →